Smallpox: a potential agent of bioterrorism (Q35077233)

6 August 2017

1 reference

title

Smallpox: a potential agent of bioterrorism (English)

1 reference

6 August 2017

0 references

1 reference

Richard J Whitley

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

57

1 reference

6 August 2017

issue

1-2

1 reference

6 August 2017

page(s)

7-12

1 reference

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Topical cidofovir for severe molluscum contagiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Smallpox in Tripolitania, 1946; an epidemiological and clinical study of 500 cases, including trials of penicillin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

The persistence of neutralizing antibodies after revaccination against smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

A case of human orf in an immunocompromised patient treated successfully with cidofovir cream

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Smallpox as a Biological Weapon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Complications of smallpox vaccination, 1968.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Smallpox research activities: U.S. interagency collaboration, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Smallpox in Europe, 1950-1971

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Epidemiology of smallpox in West Pakistan. I. Acquired immunity and the distribution of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Immunologic responses to vaccinia vaccines administered by different parenteral routes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Modeling potential responses to smallpox as a bioterrorist weapon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Experience of anti-vaccinia immunoglobulin in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900195-X

7 January 2021

10.1016/S0166-3542(02)00195-X

Identifiers

DOI

1 reference

6 August 2017

1 reference